BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Atrium Biotechnologies Inc.
1405 boul. du Parc-Technologique
Quebec G1P 4P5, Canada
Phone: (418) 652-1116; Fax: (418) 652-0151
Web: www.atrium-bio.com
E-mail: atrium@atrium-bio.com
KEY PERSONNEL: Pierre Laurin, Ph.D.; Chairman
Luc Dupont; President and CEO
Richard Bordeleau; President, Health and Nutrition
Charles Boulanger; President, Active Ingredients and Specialty Chemicals
John Dempsey; VP, Finance and CFO
EMPLOYEES: 234 employees
HISTORY: Founded in January 2000
Member--Biotechnology Industry Organization
Acquired ADF Chimie S/A (5/02)
Acquired Siricie SA (11/03)
Acquired Pure Encapsulations Inc. (3/04)
Acquired Multichem (1/05)
Acquired HVL Inc. and Douglas Laboratories (12/05)
MultiChem subsidiary acquired Amisol Co. Ltd. (5/06)
Acquired assets of Douglas Laboratories Canada (9/06)
STOCK-FINANCIAL HISTORY: TSX--ATB
IPO--6.250M shares at $12/share, $75M (3/05)
Revenue $200.9M (YE 05) compared to $136.2M (YE 04)
Net income $14.3M (YE 05) compared to $10.1M (YE 04)
Earnings per share $0.51/share (YE 05) compared to $0.44/share (YE 04)
Total assets $298.2M (YE 05) compared to $138.9M (YE 04)
SUBSIDIARIES/DIVISIONS: Atrium Biotech USA--Fairfield, N.J.
Unipex SA--Ruiel-Malmaison, France
Pure Encapsulations Inc.--Sudbury, Mass.
Chimiray--Ruiel-Malmaison, France
Atrium Biotech Europe--Marly le Roi, France
Multichem - Quebec--Boucherville, Canada
SUBSIDIARY OF: Aeterna Zentaris Inc. (see separate entry)
BUSINESS STRATEGY: Acquisition program:
-Acquisition of nutritional supplement products or companies
-Acquisition of companies specializing in the manufacturing of active
ingredients and specialty products
-Acquisition of cosmetic active ingredient lines or companies
Inlicensing program:
-Prospect for new products and new technologies among established or
emerging biotech companies and specialized research centres. Atrium
Biotechnologies can offer its strategic partners rapid access to a network of
leading customers
RESEARCH & DEVELOPMENT: New products and new versions of existing products in response to client
requests
Atrium has a patented molecular separation technology platform
PRODUCTS ON MARKET: More than 1,500 active ingredients and specialty chemicals and 400 health
and nutrition finished products
Copyright ©2006 AHC Media ® 53